Price | 53.62 | EPS | 5 | |
Shares | 5 | P/E | 12 | |
MCap | 274 | P/FCF | 13 | |
Net Debt | 14 | EBIT | 31 | |
TEV | 289 | TEV/EBIT | 9 | TTM 2019-09-30, in MM, except price, ratios |
10-Q | 2020-09-30 | Filed 2020-10-30 |
10-Q | 2020-06-30 | Filed 2020-08-06 |
10-Q | 2020-03-31 | Filed 2020-05-01 |
10-K | 2019-12-31 | Filed 2020-03-06 |
10-Q | 2019-09-30 | Filed 2019-11-01 |
10-Q | 2019-06-30 | Filed 2019-08-02 |
10-Q | 2019-03-31 | Filed 2019-05-03 |
10-K | 2018-12-31 | Filed 2019-03-08 |
10-Q | 2018-09-30 | Filed 2018-11-08 |
10-Q | 2018-06-30 | Filed 2018-08-03 |
10-Q | 2018-03-31 | Filed 2018-05-04 |
10-K | 2017-12-31 | Filed 2018-03-09 |
10-Q | 2017-09-30 | Filed 2017-11-03 |
10-Q | 2017-06-30 | Filed 2017-08-04 |
10-Q | 2017-03-31 | Filed 2017-05-05 |
10-K | 2016-12-31 | Filed 2017-03-10 |
10-Q | 2016-09-30 | Filed 2016-11-04 |
10-Q | 2016-06-30 | Filed 2016-08-05 |
10-Q | 2016-03-31 | Filed 2016-05-06 |
10-K | 2015-12-31 | Filed 2016-03-11 |
10-Q | 2015-09-30 | Filed 2015-11-09 |
10-Q | 2015-06-30 | Filed 2015-08-06 |
10-Q | 2015-03-31 | Filed 2015-05-05 |
10-K | 2014-12-31 | Filed 2015-03-12 |
10-Q | 2014-09-30 | Filed 2014-11-07 |
10-Q | 2014-06-30 | Filed 2014-08-08 |
10-Q | 2014-03-31 | Filed 2014-05-02 |
10-K | 2013-12-31 | Filed 2014-03-14 |
10-Q | 2013-09-30 | Filed 2013-11-07 |
10-Q | 2013-06-30 | Filed 2013-08-09 |
10-Q | 2013-03-31 | Filed 2013-05-03 |
10-K | 2012-12-31 | Filed 2013-03-15 |
10-Q | 2012-09-30 | Filed 2012-11-08 |
10-Q | 2012-06-30 | Filed 2012-08-09 |
10-Q | 2012-03-31 | Filed 2012-05-08 |
10-K | 2011-12-31 | Filed 2012-03-14 |
10-Q | 2011-09-30 | Filed 2011-11-07 |
10-Q | 2011-06-30 | Filed 2011-08-09 |
10-Q | 2011-03-31 | Filed 2011-05-06 |
10-K | 2010-12-31 | Filed 2011-03-11 |
10-Q | 2010-09-30 | Filed 2010-11-05 |
10-Q | 2010-06-30 | Filed 2010-08-05 |
10-Q | 2010-03-31 | Filed 2010-05-06 |
10-K | 2009-12-31 | Filed 2010-03-15 |
8-K | 2020-10-30 | |
8-K | 2020-10-28 | |
8-K | 2020-08-06 | |
8-K | 2020-05-05 | |
8-K | 2020-05-01 | |
8-K | 2020-04-13 | |
8-K | 2020-04-09 | |
8-K | 2020-03-16 | |
8-K | 2020-03-06 | |
8-K | 2019-11-01 | |
8-K | 2019-08-02 | |
8-K | 2019-05-07 | |
8-K | 2019-05-03 | |
8-K | 2019-03-08 | |
8-K | 2018-12-31 | |
8-K | 2018-11-19 | |
8-K | 2018-11-08 | |
8-K | 2018-08-03 | |
8-K | 2018-05-08 | |
8-K | 2018-05-04 | |
8-K | 2018-03-09 |
Part I - Financial Information |
Item 1. Financial Statements |
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations |
Item 3. Quantitative and Qualitative Disclosures About Market Risk |
Item 4. Controls and Procedures |
Part II - Other Information |
Item 1. Legal Proceedings |
Item 1A. Risk Factors |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
Item 3. Defaults Upon Senior Securities |
Item 4. Mine Safety Disclosures |
Item 5. Other Information |
Item 6. Exhibits |
EX-31.1 | plpc-ex311_10.htm |
EX-31.2 | plpc-ex312_8.htm |
EX-32.1 | plpc-ex321_7.htm |
EX-32.2 | plpc-ex322_6.htm |
Balance Sheet | Income Statement | Cash Flow |
---|---|---|
Assets, Equity
|
Rev, G Profit, Net Income
|
Ops, Inv, Fin
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
(Mark One)
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
OR
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number:
(Exact Name of Registrant as Specified in Its Charter)
|
| |
(State or Other Jurisdiction of Incorporation or Organization) |
| (I.R.S. Employer Identification No.) |
|
| |
|
| |
(Address of Principal Executive Office) |
| (Zip Code) |
(
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
| ☐ |
| |
| ☒ |
|
|
|
| |||
Non-accelerated filer |
| ☐ |
| Smaller reporting company |
| |
|
|
|
|
|
|
|
Emerging growth company |
| |
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
The number of common shares outstanding as of October 26, 2020:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading Symbol |
| Name of exchange on which registered |
|
| |
| |
Table of Contents
|
|
|
| Page |
|
|
|
|
|
|
| |||
|
|
|
|
|
Item 1. |
|
| 3 | |
|
|
|
|
|
Item 2. |
| Management’s Discussion and Analysis of Financial Condition and Results of Operations |
| 23 |
|
|
|
|
|
Item 3. |
|
| 34 | |
|
|
|
|
|
Item 4. |
|
| 34 | |
|
|
|
|
|
|
| |||
|
|
|
|
|
Item 1. |
|
| 35 | |
|
|
|
|
|
Item 1A. |
|
| 35 | |
|
|
|
|
|
Item 2. |
|
| 35 | |
|
|
|
|
|
Item 3. |
|
| 36 | |
|
|
|
|
|
Item 4. |
|
| 36 | |
|
|
|
|
|
Item 5. |
|
| 36 | |
|
|
|
|
|
Item 6. |
|
| 36 | |
|
|
|
|
|
| 37 |
2
PART I – FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
PREFORMED LINE PRODUCTS COMPANY
CONSOLIDATED BALANCE SHEETS
|
| September 30, 2020 |
|
| December 31, 2019 |
| ||
(Thousands of dollars, except share and per share data) |
| (Unaudited) |
|
|
|
|
| |
ASSETS |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
| $ | |
|
| $ | |
|
Accounts receivable, less allowances of $ |
|
| |
|
|
| |
|
Inventories - net |
|
| |
|
|
| |
|
Prepaids |
|
| |
|
|
| |
|
Prepaid taxes |
|
| |
|
|
| |
|
Other current assets |
|
| |
|
|
| |
|
TOTAL CURRENT ASSETS |
|
| |
|
|
| |
|
Property, plant and equipment - net |
|
| |
|
|
| |
|
Operating lease, right-of-use assets |
|
| |
|
|
| |
|
Intangibles - net |
|
| |
|
|
| |
|
Goodwill |
|
| |
|
|
| |
|
Deferred income taxes |
|
| |
|
|
| |
|
Other assets |
|
| |
|
|
| |
|
TOTAL ASSETS |
| $ | |
|
| $ | |
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
Trade accounts payable |
| $ | |
|
| $ | |
|
Notes payable to banks |
|
| |
|
|
| |
|
Operating lease liabilities, current |
|
| |
|
|
| |
|
Current portion of long-term debt |
|
| |
|
|
| |
|
Accrued compensation and amounts withheld from employees |
|
| |
|
|
| |
|
Accrued expenses and other liabilities |
|
| |
|
|
| |
|
Accrued profit-sharing and other benefits |
|
| |
|
|
| |
|
Dividends payable |
|
| |
|
|
| |
|
Income taxes payable |
|
| |
|
|
| |
|
TOTAL CURRENT LIABILITIES |
|
| |
|
|
| |
|
Long-term debt, less current portion |
|
| |
|
|
| |
|
Unfunded pension obligation |
|
| |
|
|
| |
|
Operating lease liabilities, non-current |
|
| |
|
|
| |
|
Deferred income taxes |
|
| |
|
|
| |
|
Other noncurrent liabilities |
|
| |
|
|
| |
|
SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
Shareholders’ equity: |
|
|
|
|
|
|
|
|
Common shares - $ respectively |
|
| |
|
|
| |
|
Common shares issued to rabbi trust, and December 31, 2019, respectively |
|
| ( | ) |
|
| ( | ) |
Deferred compensation liability |
|
| |
|
|
| |
|
Paid-in capital |
|
| |
|
|
| |
|
Retained earnings |
|
| |
|
|
| |
|
Treasury shares, at cost, December 31, 2019, respectively |
|
| ( | ) |
|
| ( | ) |
Accumulated other comprehensive loss |
|
| ( | ) |
|
| ( | ) |
TOTAL PREFORMED LINE PRODUCTS, COMPANY SHAREHOLDERS’ EQUITY |
|
| |
|
|
| |
|
Noncontrolling interest |
|
| |
|
|
| |
|
TOTAL SHAREHOLDERS’ EQUITY |
|
| |
|
|
| |
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
| $ | |
|
| $ | |
|
See notes to consolidated financial statements (unaudited).
3
PREFORMED LINE PRODUCTS COMPANY
STATEMENTS OF CONSOLIDATED INCOME
(UNAUDITED)
|
| Three Months Ended September 30 |
|
| Nine Months Ended September 30 |
| ||||||||||
|
| 2020 |
|
| 2019 |
|
| 2020 |
|
| 2019 |
| ||||
(Amounts in thousands of dollars, except earnings per share data) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
| $ | |
|
| $ | |
|
| $ | |
|
| $ | |
|
Cost of products sold |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
GROSS PROFIT |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Costs and expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
General and administrative |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Research and engineering |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Other operating expense - net |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
OPERATING INCOME |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Interest expense |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
Other income (expense) - net |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
| |
|
|
| ( | ) |
|
| |
|
|
| ( | ) |
INCOME BEFORE INCOME TAXES |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Income tax expense |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
NET INCOME |
| $ | |
|
| $ | |
|
| $ | |
|
| $ | |
|
Net income (loss) attributable to noncontrolling interests |
|
| ( | ) |
|
| ( | ) |
|
| |
|
|
| ( | ) |
NET INCOME ATTRIBUTABLE TO PREFORMED LINE PRODUCTS COMPANY SHAREHOLDERS |
| $ | |
|
| $ | |
|
| $ | |
|
| $ | |
|
AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Diluted |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
EARNINGS PER SHARE OF COMMON STOCK ATTRIBUTABLE TO PREFORMED LINE PRODUCTS COMPANY SHAREHOLDERS: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
| $ | |
|
| $ | |
|
| $ | |
|
| $ | |
|
Diluted |
| $ | |
|
| $ | |
|
| $ | |
|
| $ | |
|
See notes to consolidated financial statements (unaudited).
4
PREFORMED LINE PRODUCTS COMPANY
STATEMENTS OF CONSOLIDATED COMPREHENSIVE INCOME (LOSS)
(UNAUDITED)
|
| Three Months Ended September 30 |
|
| Nine Months Ended September 30 |
| ||||||||||
|
| 2020 |
|
| 2019 |
|
| 2020 |
|
| 2019 |
| ||||
(Thousands of dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
| $ | |
|
| $ | |
|
| $ | |
|
| $ | |
|
Other comprehensive income (loss), net of tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
|
| |
|
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
Recognized net actuarial gain (net of tax provision of $ |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Other comprehensive (income) loss, net of tax |
|
| |
|
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
Comprehensive (income) loss attributable to noncontrolling interests |
|
| ( | ) |
|
| ( | ) |
|
| |
|
|
| ( | ) |
Comprehensive income attributable to Preformed Line Products Company shareholders |
| $ | |
|
| $ | |
|
| $ | |
|
| $ | |
|
See notes to consolidated financial statements (unaudited).
5
PREFORMED LINE PRODUCTS COMPANY
STATEMENTS OF CONSOLIDATED CASH FLOWS
(UNAUDITED)
|
| Nine Months Ended September 30 |
| |||||
|
| 2020 |
|
| 2019 |
| ||
(Thousands of dollars) |
|
|
|
|
|
|
|
|
OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|
Net income |
| $ | |
|
| $ | |
|
Adjustments to reconcile net income to net cash provided by (used in) operations: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
| |
|
|
| |
|
Provision for accounts receivable allowances |
|
| |
|
|
| |
|
Provision for inventory reserves |
|
| |
|
|
| |
|
Deferred income taxes |
|
| |
|
|
| ( | ) |
Share-based compensation expense |
|
| |
|
|
| |
|
Gain (loss) on sale of property and equipment |
|
| |
|
|
| ( | ) |
Other - net |
|
| ( | ) |
|
| ( | ) |
Changes in operating assets and liabilities |
|
|
|
|
|
|
|
|
Accounts receivable |
|
| ( | ) |
|
| ( | ) |
Inventories |
|
| ( | ) |
|
| ( | ) |
Trade accounts payable and accrued liabilities |
|
| |
|
|
| |
|
Income taxes - net |
|
| |
|
|
| |
|
Contributions to company pension plan |
|
| ( | ) |
|
| |
|
Other - net |
|
| ( | ) |
|
| ( | ) |
NET CASH PROVIDED BY OPERATING ACTIVITIES |
|
| |
|
|
| |
|
INVESTING ACTIVITIES |
|
|
|
|
|
|
|
|
Capital expenditures |
|
| ( | ) |
|
| ( | ) |
Proceeds from the sale of property and equipment |
|
| |
|
|
| |
|
Purchase of marketable securities |
|
| |
|
|
| ( | ) |
Proceeds from marketable securities |
|
| |
|
|
| |
|
Purchase of company owned life insurance policy |
|
| |
|
|
| ( | ) |
Acquisition, net of cash acquired |
|
| |
|
|
| ( | ) |
NET CASH USED IN INVESTING ACTIVITIES |
|
| ( | ) |
|
| ( | ) |
FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
Increase (decrease) in notes payable to banks |
|
| |
|
|
| ( | ) |
Proceeds from long-term debt |
|
| |
|
|
| |
|
Payments of long-term debt |
|
| ( | ) |
|
| ( | ) |
Dividends paid |
|
| ( | ) |
|
| ( | ) |
Proceeds from issuance of common shares |
|